Identification of drug candidates that enhance pyrazinamide activity from a clinical drug library
Posted 04 Mar 2017
bioRxiv DOI: 10.1101/113704 (published DOI: 10.1038/emi.2017.23)
Posted 04 Mar 2017
Tuberculosis (TB) remains a leading cause of morbidity and mortality globally. The current TB therapy takes at least 6 months for drug-susceptible TB and 9-24 months for MDR-TB. The lengthy therapy is thought to be due to M. tuberculosis persisters that are not effectively killed by the current TB drugs. However, pyrazinamide (PZA) is an indispensable frontline TB drug that kills M. tuberculosis persisters and plays a critical role in shortening the treatment. In this study, we explored the idea of identifying FDA-approved drugs that enhance PZA activity as a rapid and efficient approach to developing more effective treatment as opposed to new drug development. To achieve that, we screened the clinical drug library and identified various drug candidates that could enhance PZA activity in vitro against a 3-month-old M. tuberculosis culture. These findings are of particular interest and may have implications for improved treatment of drug-susceptible TB and drug-resistant TB. Further studies are needed to determine if these drugs can shorten TB treatment in vivo in animal models and if so in patients.
- Downloaded 356 times
- Download rankings, all-time:
- Site-wide: 52,894 out of 101,121
- In microbiology: 3,972 out of 8,975
- Year to date:
- Site-wide: 71,044 out of 101,121
- Since beginning of last month:
- Site-wide: 56,609 out of 101,121
Downloads over time
Distribution of downloads per paper, site-wide
- 20 Oct 2020: Support for sorting preprints using Twitter activity has been removed, at least temporarily, until a new source of social media activity data becomes available.
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!